VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2018 Update
- GDME321317PD
- Pages: 69
- August 2018
- Region : Asia
- GlobalData
- Equity Research Report
- Details
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Details
Summary
VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company VolitionRX Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
VolitionRX Ltd Company Overview 6
VolitionRX Ltd Company Snapshot 6
VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
VolitionRX Ltd-Pipeline Analysis Overview 8
VolitionRX Ltd-Key Facts 8
VolitionRX Ltd-Major Products and Services 9
VolitionRX Ltd Pipeline Products by Development Stage 10
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14
VolitionRX Ltd Pipeline Products Overview 16
HyperGenomics Diagnostic Test-Colon Cancer 16
HyperGenomics Diagnostic Test-Colon Cancer Product Overview 16
HyperGenomics Diagnostic Test-Leukaemia 17
HyperGenomics Diagnostic Test-Leukaemia Product Overview 17
HyperGenomics Diagnostic Test-Prostate Cancer 18
HyperGenomics Diagnostic Test-Prostate Cancer Product Overview 18
Nu.Q CRC Screening Test 19
Nu.Q CRC Screening Test Product Overview 19
Nu.Q CRC Screening Test Clinical Trial 20
Nu.Q CRC Symptomatic Test 21
Nu.Q CRC Symptomatic Test Product Overview 21
Nu.Q CRC Triage Test 22
Nu.Q CRC Triage Test Product Overview 22
Nu.Q Frontline Asymptomatic CRC Screening Test 23
Nu.Q Frontline Asymptomatic CRC Screening Test Product Overview 23
Nu.Q Frontline Asymptomatic CRC Screening Test Clinical Trial 24
NuQ-A Androgen Receptor Cell Culture ELISA Kit 25
NuQ-A Androgen Receptor Cell Culture ELISA Kit Product Overview 25
NuQ-A EZH2 Cell Culture ELISA Kit 26
NuQ-A EZH2 Cell Culture ELISA Kit Product Overview 26
NuQ-A HMGB1 Cell Culture ELISA Kit 27
NuQ-A HMGB1 Cell Culture ELISA Kit Product Overview 27
NuQ-A Oestrogen Receptor Cell Culture ELISA Kit 28
NuQ-A Oestrogen Receptor Cell Culture ELISA Kit Product Overview 28
NuQ-A Progesterone Receptor Cell Culture ELISA Kit 29
NuQ-A Progesterone Receptor Cell Culture ELISA Kit Product Overview 29
NuQ-Prostate Cancer 30
NuQ-Prostate Cancer Product Overview 30
NuQ-Prostate Cancer Clinical Trial 31
NuQ-T001 Total Nucleosome ELISA Kit 32
NuQ-T001 Total Nucleosome ELISA Kit Product Overview 32
NuQ Diagnostic Test-Lung Cancer 33
NuQ Diagnostic Test-Lung Cancer Product Overview 33
NuQ Diagnostic Test-Lung Cancer Clinical Trial 34
NuQ Diagnostic Test-Pancreatic Cancer 35
NuQ Diagnostic Test-Pancreatic Cancer Product Overview 35
NuQ Diagnostic Test-Pancreatic Cancer Clinical Trial 36
NuQ Endo 37
NuQ Endo Product Overview 37
NuQ Endo Clinical Trial 38
NuQ T003 Assay-Colorectal Cancer 39
NuQ T003 Assay-Colorectal Cancer Product Overview 39
NuQ V001 Assay-Colorectal Cancer 40
NuQ V001 Assay-Colorectal Cancer Product Overview 40
NuQ X001S Assay-Colorectal Cancer 41
NuQ X001S Assay-Colorectal Cancer Product Overview 41
NuQ X001S Assay-Colorectal Cancer Clinical Trial 42
NuQ-B 43
NuQ-B Product Overview 43
NuQ-IHC 44
NuQ-IHC Product Overview 44
NuQ-M Gamma-H2AX Cell Culture ELISA Kit 45
NuQ-M Gamma-H2AX Cell Culture ELISA Kit Product Overview 45
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit 46
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview 46
NuQ-M H4K16(Ac) Cell Culture ELISA Kit 47
NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview 47
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit 48
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview 48
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit 49
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview 49
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit 50
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview 50
NuQ-V 51
NuQ-V Product Overview 51
NuQ-V mH2A1.1 Cell Culture ELISA Kit 52
NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview 52
NuQ-V mH2A2 Cell Culture ELISA Kit 53
NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview 53
NuQ-X Hydroxymethylated DNA Cell Culture Kit 54
NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview 54
NuQ-X Methylated DNA Cell Culture Kit 55
NuQ-X Methylated DNA Cell Culture Kit Product Overview 55
VolitionRX Ltd-Key Competitors 56
VolitionRX Ltd-Key Employees 57
VolitionRX Ltd-Locations And Subsidiaries 58
Head Office 58
Other Locations & Subsidiaries 58
Recent Developments 59
VolitionRX Ltd, Recent Developments 59
Jul 10, 2018: Volition expands clinical development of Nu.Q to Asia Pacific 59
May 10, 2018: VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 59
May 09, 2018: VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 60
Mar 07, 2018: VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 60
Mar 01, 2018: VolitionRX Announces Full Fiscal Year 2017 Financial Results and Business Update 61
Feb 26, 2018: VolitionRx Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer 62
Feb 05, 2018: VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark 63
Jan 03, 2018: VolitionRx Releases Letter to Shareholders Including Status Update on Key Clinical Milestone 63
Nov 09, 2017: VolitionRx Announces Third Quarter 2017 Financial Results and Business Update 64
Sep 22, 2017: VolitionRx Announces the Initial Sale of its New Nu.Q Research Kits 65
Appendix 66
Methodology 66
About GlobalData 69
Contact Us 69
Disclaimer 69
List Of Figure
List of Figures
VolitionRX Ltd Pipeline Products by Equipment Type 7
VolitionRX Ltd Pipeline Products by Development Stage 10
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14
List Of Table
List of Tables
VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
VolitionRX Ltd Pipeline Products by Equipment Type 7
VolitionRX Ltd Pipeline Products by Indication 7
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 7
VolitionRX Ltd, Key Facts 8
VolitionRX Ltd, Major Products and Services 9
VolitionRX Ltd Number of Pipeline Products by Development Stage 10
VolitionRX Ltd Pipeline Products Summary by Development Stage 11
VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14
VolitionRX Ltd Ongoing Clinical Trials Summary 15
HyperGenomics Diagnostic Test-Colon Cancer-Product Status 16
HyperGenomics Diagnostic Test-Colon Cancer-Product Description 16
HyperGenomics Diagnostic Test-Leukaemia-Product Status 17
HyperGenomics Diagnostic Test-Leukaemia-Product Description 17
HyperGenomics Diagnostic Test-Prostate Cancer-Product Status 18
HyperGenomics Diagnostic Test-Prostate Cancer-Product Description 18
Nu.Q CRC Screening Test-Product Status 19
Nu.Q CRC Screening Test-Product Description 19
Nu.Q CRC Screening Test-A Large Multi-center US Clinical Study of Nu.Q Assay in the Screening of Colorectal Cancer 20
Nu.Q CRC Screening Test-Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer 20
Nu.Q CRC Symptomatic Test-Product Status 21
Nu.Q CRC Symptomatic Test-Product Description 21
Nu.Q CRC Triage Test-Product Status 22
Nu.Q CRC Triage Test-Product Description 22
Nu.Q Frontline Asymptomatic CRC Screening Test-Product Status 23
Nu.Q Frontline Asymptomatic CRC Screening Test-Product Description 23
Nu.Q Frontline Asymptomatic CRC Screening Test-Asymptomatic Colorectal Cancer (CRC) Frontline Screening Study 24
NuQ-A Androgen Receptor Cell Culture ELISA Kit-Product Status 25
NuQ-A Androgen Receptor Cell Culture ELISA Kit-Product Description 25
NuQ-A EZH2 Cell Culture ELISA Kit-Product Status 26
NuQ-A EZH2 Cell Culture ELISA Kit-Product Description 26
NuQ-A HMGB1 Cell Culture ELISA Kit-Product Status 27
NuQ-A HMGB1 Cell Culture ELISA Kit-Product Description 27
NuQ-A Oestrogen Receptor Cell Culture ELISA Kit-Product Status 28
NuQ-A Oestrogen Receptor Cell Culture ELISA Kit-Product Description 28
NuQ-A Progesterone Receptor Cell Culture ELISA Kit-Product Status 29
NuQ-A Progesterone Receptor Cell Culture ELISA Kit-Product Description 29
NuQ-Prostate Cancer-Product Status 30
NuQ-Prostate Cancer-Product Description 30
NuQ-Prostate Cancer-A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer 31
NuQ-Prostate Cancer-Evaluate the Accuracy of Nu.Q Assay in Diagnosis of Aggressive Prostate Cancer 31
NuQ-Prostate Cancer-Multicenter study to evaluate ability of NuQ to detect prostate cancer 31
NuQ-T001 Total Nucleosome ELISA Kit-Product Status 32
NuQ-T001 Total Nucleosome ELISA Kit-Product Description 32
NuQ Diagnostic Test-Lung Cancer-Product Status 33
NuQ Diagnostic Test-Lung Cancer-Product Description 33
NuQ Diagnostic Test-Lung Cancer-Detection of Lung Cancer with NuQ Blood Test 34
NuQ Diagnostic Test-Lung Cancer-Study to evaluate NuQ for early detection of 27 most prevalent cancers; and to evaluate differences in nucleosome structures between cancers 34
NuQ Diagnostic Test-Pancreatic Cancer-Product Status 35
NuQ Diagnostic Test-Pancreatic Cancer-Product Description 35
NuQ Diagnostic Test-Pancreatic Cancer-Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer 36
NuQ Endo-Product Status 37
NuQ Endo-Product Description 37
NuQ Endo-Study to Evaluate the Efficacy of Nu.Q Platform Technology in Diagnosis of Endometriosis 38
NuQ T003 Assay-Colorectal Cancer-Product Status 39
NuQ T003 Assay-Colorectal Cancer-Product Description 39
NuQ V001 Assay-Colorectal Cancer-Product Status 40
NuQ V001 Assay-Colorectal Cancer-Product Description 40
NuQ X001S Assay-Colorectal Cancer-Product Status 41
NuQ X001S Assay-Colorectal Cancer-Product Description 41
NuQ X001S Assay-Colorectal Cancer-Evaluate the Accuracy of NuQ Assays as an Initial Screening Tool for Detecting Colorectal Cancer: A Retrospective Study 42
NuQ-B-Product Status 43
NuQ-B-Product Description 43
NuQ-IHC-Product Status 44
NuQ-IHC-Product Description 44
NuQ-M Gamma-H2AX Cell Culture ELISA Kit-Product Status 45
NuQ-M Gamma-H2AX Cell Culture ELISA Kit-Product Description 45
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit-Product Status 46
NuQ-M H3K27(Me)3 Cell Culture ELISA Kit-Product Description 46
NuQ-M H4K16(Ac) Cell Culture ELISA Kit-Product Status 47
NuQ-M H4K16(Ac) Cell Culture ELISA Kit-Product Description 47
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit-Product Status 48
NuQ-M H4K20(Me)3 Cell Culture ELISA Kit-Product Description 48
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit-Product Status 49
NuQ-M H4Pan(Ac) Cell Culture ELISA Kit-Product Description 49
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit-Product Status 50
NuQ-M Ubiquityl H2A Cell Culture ELISA Kit-Product Description 50
NuQ-V-Product Status 51
NuQ-V-Product Description 51
NuQ-V mH2A1.1 Cell Culture ELISA Kit-Product Status 52
NuQ-V mH2A1.1 Cell Culture ELISA Kit-Product Description 52
NuQ-V mH2A2 Cell Culture ELISA Kit-Product Status 53
NuQ-V mH2A2 Cell Culture ELISA Kit-Product Description 53
NuQ-X Hydroxymethylated DNA Cell Culture Kit-Product Status 54
NuQ-X Hydroxymethylated DNA Cell Culture Kit-Product Description 54
NuQ-X Methylated DNA Cell Culture Kit-Product Status 55
NuQ-X Methylated DNA Cell Culture Kit-Product Description 55
VolitionRX Ltd, Key Employees 57
VolitionRX Ltd, Subsidiaries 58
Glossary 68
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Products and Companies
Products
VolitionRX Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
SciGen Ltd
PathGEN Dx Pte. Ltd.
Kino Biotech Co Ltd
Epigenomics AG
Abbott Laboratories
Ab Sciex Pte Ltd
Related Reports
Page 152 | 
May 2019
Page 91 | December 2018
Page 40 | June 2018
Page 102 | June 2018
Page 54 | February 2018
